Source: Annual Congress 2011 - Coping and lifestyle in childhood asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. S. Baek, Y. S. Jang, J. H. Kim, J. W. Oh, H. B. Lee (Seoul, Seioul, Republic Of Korea). Late-breaking abstract: Urinary leukotriene E₄/exhaled nitric oxide ratio as a predictor of exercise-induced bronchoconstriction control by oral montelukast or inhaled corticosteroid. Eur Respir J 2011; 38: Suppl. 55, 4249

Member's Comments

No comment yet.

Related content which might interest you: Effect of inhaled steroids and long-acting β2 agonists on exhaled nitric oxide (eNO) in asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 270s Year: 2004 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Effect of once-daily inhaled glucocorticosteroid administration on exhaled nitric oxide in controlled asthma patients Source: Annual Congress 2008 - Pathogenesis and treatment of asthma and COPD Year: 2008 Comparison of long-acting inhaled beta2–agonists plus inhaled steroids versus increasing dose of inhaled steroids on exhaled nitric oxide among asthmatic children poorly controlled Source: Eur Respir J 2005; 26: Suppl. 49, 617s Year: 2005 Urinary leukotriene E4 and exhaled nitric oxide on recovery from exercise-induced bronchospasm in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006 Effect of formoterol with or without budesonide in repeated low-dose allergen challenge Source: Eur Respir J 2009; 33: 747-753 Year: 2009 Bronchial nitric oxide output predicts responsiveness to inhaled steroids in COPD Source: Eur Respir J 2004; 24: Suppl. 48, 429s Year: 2004 Effect of adding montelukast to budesonide treatment on exhaled nitric oxide in mild to moderate asthma Source: Eur Respir J 2004; 24: Suppl. 48, 259s Year: 2004 Are exhaled nitric oxide and airway hyperresponsiveness good predictive markers of inhaled corticosteroids dose reduction failures in children? Source: Annual Congress 2003 - Role of exhaled NO in diagnosis and therapy of childhood asthma Year: 2003 The relationship between exhaled nitric oxide and compliance/adherence in patients with bronchial asthma using inhaled corticosteroids Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012 Exhaled NO and assessment of anti-inflammatory effects of inhaled steroid: dose-response relationship Source: Eur Respir J 2002; 20: 601-608 Year: 2002 Exhaled nitric oxide and inhaled corticosteroid dose reduction in asthma: a cohort study Source: Eur Respir J 2014; 44: 1705-1707 Year: 2014 Non-adherence to inhaled corticosteroid therapy as an explanation for persistently elevated exhaled nitric oxide levels in patients with asthma: Effect of directly observed therapy with inhaled corticosteroids (DOT-ICS) Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Effect of systemic and extra-fine particle inhaled corticosteroids on corrected alveolar nitric oxide (CANO) in COPD Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Dose response to inhaled fluticasone/salmeterol measured with extended exhaled nitric oxide in refractory asthma Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010 Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Tapering oral corticosteroids in severe asthma is associated with a decrease in fractional exhaled nitric oxide Source: Annual Congress 2011 - Mechanism and monitoring of airway diseases Year: 2011 Inhaled salbutamol significantly affects the bronchial production of nitric oxide in normal subjects Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 Fractional exhaled nitric oxide (FeNO) could be a good predictor for the effectiveness of inhaled corticosteroid (ICS) in patients with COPD Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases Year: 2009 Onset of action of inhaled corticosteroids on bronchial and alveolar nitric oxide output Source: Virtual Congress 2020 – Exhaled biomarkers of asthma and the asthma burden Year: 2020